Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600132452Phase 4Recruiting
Phase 4 trial of esketamine in postoperative pain and postoperative fatigue (2 arms), sponsored by Hefei Second People's Hospital. Primary endpoints: Incidence of postoperative fatigue syndrome and Quality of Recovery-15 score. Started Sep 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600132452.